Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-037699
Filing Date
2019-02-13
Accepted
2019-02-13 14:36:03
Documents
2
Group Members
ESSEX WOODLANDS FUND IX-GP, L.P.ESSEX WOODLANDS IX, LLCEW HEALTHCARE PARTNERS-A L.P.MARTIN P. SUTTERPETRI VAINIOR. SCOTT BARRYRONALD EASTMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d699436dsc13da.htm SC 13D/A 167303
2 EX-99.1 d699436dex991.htm EX-99.1 16100
  Complete submission text file 0001193125-19-037699.txt   185470
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81613 | Film No.: 19596313
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 281-364-1555
EW Healthcare Partners, L.P. (Filed by) CIK: 0001612343 (see all company filings)

EIN.: 471044766 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A